Showing results (31-40 of 1,997) with videos related to
Sort By:
Pageof 200
Drug Metabolism and Drug Interactions|January 1, 1994
Absolute bioavailability of glimepiride (Amaryl) after oral administrationM Badian, A Korn, K H Lehr, et al.Drug Metabolism and Drug Interactions|January 1, 1996
Pharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administrationM Badian, A Korn, K H Lehr, et al.Drug Metabolism and Drug Interactions|January 1, 1994
Dose linearity assessment of glimepiride (Amaryl) tablets in healthy volunteersV Malerczyk, M Badian, A Korn, et al.Infection|May 1, 1987
Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivateL Maass, V Malerczyk, M Verho, et al.Diabetologia|December 1, 1996
Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairmentB Rosenkranz, V Profozic, Z Metelko, et al.Infection|May 1, 1987
Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivativeV Malerczyk, L Maass, M Verho, et al.Herz|October 1, 1980
[Use of mezlocillin in open heart surgery (author's transl)]P Kalmar, H J Krebber, C Müller-Schwefe, et al.Clinical Pharmacology and Therapeutics|October 1, 1993
Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysisN Veys, N Lameire, V Malerczyk, et al.European Journal of Cardiology|November 1, 1978
Analysis of left and right ventricular size and shape, as determined from human casts. Description of the method and its validationP E Lange, D Onnasch, F L Farr, et al.Clinical Pharmacokinetics|November 1, 1991
Ofloxacin pharmacokinetics in chronic renal failure and dialysisN Lameire, B Rosenkranz, V Malerczyk, et al.Pageof 200